Cadmium exposure, citrullinated vimentin and lung fibrosis. Veena B. Antony1MD, Ranu Surolia1, PhD, A. Brent Carter1, MD, and Fu Jun Li1MD, PhD. University of Alabama at Birmingham, Birmingham, AL, USA V. Antony (Birmingham, United States of America), R. Surolia (Birmingham, United States of America), A. Carter (Birmingham, United States of America), F. Li (Birmingham, United States of America)
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Antony (Birmingham, United States of America), R. Surolia (Birmingham, United States of America), A. Carter (Birmingham, United States of America), F. Li (Birmingham, United States of America). Cadmium exposure, citrullinated vimentin and lung fibrosis. Veena B. Antony1MD, Ranu Surolia1, PhD, A. Brent Carter1, MD, and Fu Jun Li1MD, PhD. University of Alabama at Birmingham, Birmingham, AL, USA. 1287
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Documentation of electronic nicotine delivery systems (ENDS) in medically admitted patients in Connolly Hospital Dublin.Fiona O’Driscoll, Shahzad Ahmed, Waheed Shah, Professor John Faul, Connolly Hospital Dublin, Dublin. Source: International Congress 2018 – Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes Year: 2018
“Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis” Alexandra M. Nanzer, Jaideep Dhariwal, Joanne Kavanagh, Andrew Hearn, Mariana Fernandes, Louise Thomson, Cris Roxas, Linda Green, Grainne D'Ancona, Sangita Agarwal, Brian D. Kent and David J. Jackson. ERJ Open Res 2019; 6: 00272-2019 Source: ERJ Open Res, 7 (1) 50451-2020; 10.1183/23120541.50451-2020 Year: 2021
“The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites” Elena K. Schneider, Rachel M. McQuade, Vincenzo C. Carbone, Felisa Reyes-Ortega, John W. Wilson, Brenda Button, Ayame Saito, Daniel P. Poole, Daniel Hoyer, Jian Li and Tony Velkov. ERJ Open Res 2018; 4: 00127-2017. Source: ERJ Open Res, 4 (4) 00127-2017-ERR; 10.1183/23120541.50127-2017 Year: 2018
“Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study.” John P. Corcoran, Ioannis Psallidas, Stephen Gerry, Francesco Piccolo, Coenraad F. Koegelenberg, Tarek Saba, Cyrus Daneshvar, Ian Fairbairn, Richard Heinink, Alex West, Andrew E. Stanton, Jayne Holme, Jack A. Kastelik, Henry Steer, Nicola J. Downer, Mohammed Haris, Emma H. Baker, Caroline F. Everett, Justin Pepperell, Thomas Bewick, Lonny Yarmus, Fabien Maldonado, Burhan Khan, Alan Hart-Thomas, Georgina Hands, Geoffrey Warwick, Duneesha De Fonseka, Maged Hassan, Mohammed Munavvar, Anur Guhan, Mitra Shahidi, Zara Pogson, Lee Dowson, Natalia D. Popowicz, Judith Saba, Neil R. Ward, Rob J. Hallifax, Melissa Dobson, Rachel Shaw, Emma L. Hedley, Assunta Sabia, Barbara Robinson, Gary S. Collins, Helen E. Davies, Ly-Mee Yu, Robert F. Miller, Nick A. Maskell and Najib M. Rahman. Eur Respir J 2020; 56: 2000130. Source: Eur Respir J, 56 (6) 2050130; 10.1183/13993003.50130-2020 Year: 2020
“Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey.” Dodge R. Lim, Anna S. Dean, Mary Rosary Taguinod-Santiago, Angeli Borbe-Reyes, Andrea Maurizio Cabibbe, Matteo Zignol, Ramon P. Basilio, Anna Marie Celina Garfin and Maria Cecilia G. Ama. Eur Respir J 2018; 51: 1702571. Source: Eur Respir J, 51 (5) 1752571; 10.1183/13993003.52571-2017 Year: 2018
Withdrawal notice for: “Circulating RNA differences between patients with stable and progressive lung function in IPF.” Britt Clynick, Helen E. Jo, Tamera J. Corte, Ian N. Glaspole, Christopher Grainge, Peter M.A. Hopkins, Paul N. Reynolds, Sally Chapman, E. Haydn Walters, Christopher Zappala, Gregory J. Keir, Wendy A. Cooper, Annabelle M. Mahar, Samantha Ellis, Nicole Goh, Svetlana Baltic, Marissa Ryan, Dino Tan and Yuben Moodley. Eur Respir J 2019; in press. Source: Eur Respir J, 54 (5) 1802115; 10.1183/13993003.02115-2018 Year: 2019
“Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.” Yael Gernez, Jeffrey Waters, Bojana Mirkovic, Gillian M. Lavelle, Colleen E. Dunn, Zoe A. Davies, Cassie Everson, Rabindra Tirouvanziam, Elana Silver, Sylvan Wallenstein, Sanjay H. Chotirmall, Noel G. McElvaney, Leonore A. Herzenberg and Richard B. Moss. Eur Respir J 2016; 47: 177–185. Source: Eur Respir J 2016; 47:1892 Year: 2016
“National and regional asthma programmes in Europe.” Olof Selroos, Maciej Kupczyk, Piotr Kuna, Piotr Lacwik, Jean Bousquet, David Brennan, Susanna Palkonen, Javier Contreras, Mark FitzGerald, Gunilla Hedlin, Sebastian L. Johnston, Renaud Louis, Leanne Metcalf, Samantha Walker, Antonio Moreno-Galdó, Nikolaos G. Papadopoulos, José Rosado-Pinto, Pippa Powell and Tari Haahtela. Eur Respir Rev 2015; 24: 474-483. Source: Eur Respir Rev, 28 (154) 195081; 10.1183/16000617.5081-2014 Year: 2019
“A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease” Simon Bax, Charlene Bredy, Aleksander Kempny, Konstantinos Dimopoulos, Anand Devaraj, Simon Walsh, Joseph Jacob, Arjun Nair, Maria Kokosi, Gregory Keir, Vasileios Kouranos, Peter M. George, Colm McCabe, Michael Wilde, Athol Wells, Wei Li, Stephen John Wort and Laura C. Price. ERJ Open Res 2018; 4: 00124-2017.Source: ERJ Open Res, 4 (3) 00124-2017-AUT; 10.1183/23120541.50124-2017 Year: 2018
“International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343–373. Source: Eur Respir J 2014; 43: 1216 Year: 2014
“International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343–373. Source: Eur Respir J, 52 (1) 1352020; 10.1183/13993003.52020-2013 Year: 2018
“Chronic thromboembolic pulmonary hypertension in Saudi Arabia: preliminary results from the SAUDIPH registry”. Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Pekka Hämmäinen, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun and Nadeen Alharbi. ERJ Open Res 2019; 6: 00218-2019. Source: ERJ Open Res, 6 (4) 00218-2019-AUT; 10.1183/23120541.50218-2019 Year: 2020
“Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort” Tom M.A. Wilkinson, Emmanuel Aris, Simon C. Bourne, Stuart C. Clarke, Mathieu Peeters, Thierry G. Pascal, Laura Taddei, Andrew C. Tuck, Viktoriya L. Kim, Kristoffer K. Ostridge, Karl J. Staples, Nicholas P. Williams, Anthony P. Williams, Stephen A. Wootton and Jeanne-Marie Devaster, on behalf of the AERIS Study Group. ERJ Open Res 2019; 5: 00248-2018. Source: ERJ Open Res, 5 (3) 00248-2018-AUT; 10.1183/23120541.50248-2018 Year: 2019
“Paediatric HERMES: European accreditation of training centres in paediatric respiratory medicine.” Sandy Sutter, Sharon Mitchell, Ernst Eber, Gunilla Hedlin, Fabio Midulla, Alexandra Niculescu, Jimmy Y. Paton, Robert Ross Russell, Monika Gappa. Breathe 2016; 12: 105–110. Source: Breathe 2016; 12: 297 Year: 2016
“Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma” Paraskevi Katsaounou, Mikaela Odemyr, Otto Spranger, Michael E. Hyland, Claus Kroegel, Lorena Garcia Conde, Robin Gore, Francesco Menzella, Christian Domingo Ribas, Mario Morais-Almeida, Matthias Gasser and Ismail Kasujee. ERJ Open Res 2018; 4: 00076-2018. Source: ERJ Open Res, 5 (1) 00076-2018-AUT; 10.1183/23120541.50076-2018 Year: 2019
“The effect of exacerbation history on outcomes in the IMPACT trial.” David M.G. Halpin, Mark T. Dransfield, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Fernando J. Martinez, Steve Pascoe, Dave Singh, Robert Wise and Gerard J. Criner. Eur Respir J 2020; 55: 1901921. Source: Eur Respir J, 55 (6) 1951921; 10.1183/13993003.51921-2019 Year: 2020
“Vitamin D and skeletal muscle strength and endurance in COPD.” Abigail S. Jackson, Dinesh Shrikrishna, Julia L. Kelly, Samuel V. Kemp, Nicholas Hart, John Moxham, Michael I. Polkey, Paul Kemp and Nicholas S. Hopkinson. Eur Respir J 2013; 41: 309–316. Source: Eur Respir J 2013; 41: 998 Year: 2013
“Characterisation of patients with interstitial pneumonia with autoimmune features.” Justin M. Oldham, Ayodeji Adegunsoye, Eleanor Valenzi, Cathryn Lee, Leah Witt, Lena Chen, Aliya N. Husain, Steven Montner, Jonathan H. Chung, Vincent Cottin, Aryeh Fischer, Imre Noth, Rekha Vij and Mary E. Strek. Eur Respir J 2016; 47: 1767–1775. Source: Eur Respir J, 49 (5) 1551565; 10.1183/13993003.51565-2015 Year: 2017
“Echocardiographic abnormalities in patients with COPD at their first hospital admission.” Xavier Freixa, Karina Portillo, Carles Paré, Judith Garcia-Aymerich, Federico P. Gomez, Marta Benet, Josep Roca, Eva Farrero, Jaume Ferrer, Carlos Fernandez-Palomeque, Josep M. Antó and Joan Albert Barberà, on behalf of the PAC-COPD Study Investigators. Eur Respir J 2013; 41: 784–791. Source: Eur Respir J 2015; 46: 1533 Year: 2015
“Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort.” Dominick E. Shaw, Ana R. Sousa, Stephen J. Fowler, Louise J. Fleming, Graham Roberts, Julie Corfield, Ioannis Pandis, Aruna T. Bansal, Elisabeth H. Bel, Charles Auffray, Chris H. Compton, Hans Bisgaard, Enrica Bucchioni, Massimo Caruso, Pascal Chanez, Barbro Dahlén, Sven-Erik Dahlen, Kerry Dyson, Urs Frey, Thomas Geiser, Maria Gerhardsson de Verdier, David Gibeon, Yi-ke Guo, Simone Hashimoto, Gunilla Hedlin, Elizabeth Jeyasingham, Pieter-Paul W. Hekking, Tim Higenbottam, Ildikó Horváth, Alan J. Knox, Norbert Krug, Veit J. Erpenbeck, Lars X. Larsson, Nikos Lazarinis, John G. Matthews, Roelinde Middelveld, Paolo Montuschi, Jacek Musial, David Myles, Laurie Pahus, Thomas Sandström, Wolfgang Seibold, Florian Singer, Karin Strandberg, Jorgen Vestbo, Nadja Vissing, Christophe von Garnier, Ian M. Adcock, Scott Wagers, Anthony Rowe, Peter Howarth, Ariane H. Wagener, Ratko Djukanovic, Peter J. Sterk and Kian Fan Chung on behalf of the U-BIOPRED Study Group. Eur Respir J 2015; 46: 1308–1321. Source: Eur Respir J, 49 (6) 1550779; 10.1183/13993003.50779-2015 Year: 2017